A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy assay and impact of biopsy
- PMID: 32863013
- DOI: 10.1016/j.fertnstert.2020.07.052
A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy assay and impact of biopsy
Abstract
Objective: To determine the predictive value of an aneuploid diagnosis with a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy (PGT-A) assay in prognosticating the failure of a successful delivery.
Design: Prospective, blinded, multicenter, nonselection study. All usable blastocysts were biopsied, and the single best morphologic blastocyst was transferred before genetic analysis. Preimplantation genetic testing for aneuploidy was performed after clinical outcome was determined. Clinical outcomes were compared to PGT-A results to calculate the predictive value of a PGT-A aneuploid diagnosis.
Setting: Fertility centers.
Patient(s): Couples undergoing their first in vitro fertilization cycle without recurrent pregnancy loss, antral follicle count < 8, or body mass index ≥ 35 kg/m2.
Intervention(s): None.
Main outcome measure(s): The primary outcome was the ability of the analytical result of aneuploid to predict failure to deliver (clinical result). A secondary outcome was the impact of the trophectoderm biopsy on sustained implantation.
Result(s): Four hundred two patients underwent 484 single, frozen, blastocyst transfers. The PGT-A aneuploid diagnosis clinical error rate was 0%. There was no difference in sustained implantation between the study group and an age-matched control group, where biopsy was not performed (47.9% vs. 45.8).
Conclusion(s): The PGT-A assay evaluated was highly prognostic of failure to deliver when an aneuploid result was obtained. Additionally, the trophectoderm biopsy had no detectable adverse impact on sustained implantation.
Clinical trial registration numbers: NCT02032264 and NCT03604107.
Keywords: Preimplantation genetic testing for aneuploidy (PGT-A); aneuploid diagnosis; impact of biopsy; nonselection study; predictive value.
Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Comment in
-
The road to validating preimplantation genetic testing for aneuploidy; are we there yet?Fertil Steril. 2021 Mar;115(3):585-586. doi: 10.1016/j.fertnstert.2020.12.029. Epub 2021 Feb 6. Fertil Steril. 2021. PMID: 33558020 No abstract available.
Similar articles
-
Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).J Assist Reprod Genet. 2019 Jan;36(1):153-157. doi: 10.1007/s10815-018-1347-6. Epub 2018 Oct 25. J Assist Reprod Genet. 2019. PMID: 30362056 Free PMC article.
-
Assessment of aneuploidy concordance between clinical trophectoderm biopsy and blastocyst.Hum Reprod. 2019 Jan 1;34(1):181-192. doi: 10.1093/humrep/dey327. Hum Reprod. 2019. PMID: 30418565
-
Noninvasive preimplantation genetic testing for aneuploidy exhibits high rates of deoxyribonucleic acid amplification failure and poor correlation with results obtained using trophectoderm biopsy.Fertil Steril. 2021 Jun;115(6):1461-1470. doi: 10.1016/j.fertnstert.2021.01.028. Epub 2021 Mar 19. Fertil Steril. 2021. PMID: 33745720
-
Transfer of the fittest: using preimplantation genetic testing for aneuploidy to select embryo(s) most likely to lead to live birth.F S Sci. 2023 May;4(2S):2-6. doi: 10.1016/j.xfss.2022.12.005. Epub 2023 Jan 18. F S Sci. 2023. PMID: 36669620 Review.
-
Chromosomal mosaicism in human blastocysts: the ultimate diagnostic dilemma.Hum Reprod Update. 2020 Apr 15;26(3):313-334. doi: 10.1093/humupd/dmz050. Hum Reprod Update. 2020. PMID: 32141501 Review.
Cited by
-
Individual culture leads to decreased blastocyst formation but does not affect pregnancy outcomes in the setting of a single, vitrified-warmed euploid blastocyst transfer.J Assist Reprod Genet. 2021 Aug;38(8):2157-2164. doi: 10.1007/s10815-021-02252-8. Epub 2021 Jun 4. J Assist Reprod Genet. 2021. PMID: 34086147 Free PMC article.
-
Acupuncture improves the live birth of patients with repeated implantation failure: a retrospective cohort study.J Tradit Chin Med. 2024 Aug;44(4):830-838. doi: 10.19852/j.cnki.jtcm.20240515.006. J Tradit Chin Med. 2024. PMID: 39066544 Free PMC article.
-
Detection of Germline Mosaicism for Robertsonian Translocation 14;14: A Case Report.J Reprod Infertil. 2024 Jan-Mar;25(1):66-71. doi: 10.18502/jri.v25i1.15202. J Reprod Infertil. 2024. PMID: 39157282 Free PMC article.
-
Extracellular vesicles secreted by human aneuploid embryos present a distinct transcriptomic profile and upregulate MUC1 transcription in decidualised endometrial stromal cells.Hum Reprod Open. 2024 Mar 12;2024(2):hoae014. doi: 10.1093/hropen/hoae014. eCollection 2024. Hum Reprod Open. 2024. PMID: 38559895 Free PMC article.
-
Should there be an "AI" in TEAM? Embryologists selection of high implantation potential embryos improves with the aid of an artificial intelligence algorithm.J Assist Reprod Genet. 2021 Oct;38(10):2663-2670. doi: 10.1007/s10815-021-02318-7. Epub 2021 Sep 17. J Assist Reprod Genet. 2021. PMID: 34535847 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical